Oxidized metabolites of linoleic acid as biomarkers of liver injury in nonalcoholic steatohepatitis

Author： Santoro Nicola   Caprio Sonia   Feldstein Ariel E  

Publisher： Future Medicine

ISSN： 1758-4299

Source： Clinical Lipidology, Vol.8, Iss.4, 2013-08, pp. : 411-418

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Where are we in the search for noninvasive nonalcoholic steatohepatitis biomarkers?

By  

HEPATOLOGY, Vol. 54, Iss. 4, 2011-10 ,pp. : 1115-1117

John Wiley & Sons Inc

Access to resources Recommend Favorite

The pan‐caspase inhibitor Emricasan (IDN‐6556) decreases liver injury and fibrosis in a murine model of non‐alcoholic steatohepatitis

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 3, 2015-03 ,pp. : 953-966

John Wiley & Sons Inc

Access to resources Recommend Favorite

Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Implications for liver transplantation

By  

LIVER TRANSPLANTATION, Vol. 24, Iss. 2, 2018-02 ,pp. : 166-170

John Wiley & Sons Inc

Access to resources Recommend Favorite

Disruption of phospholipid and bile acid homeostasis in mice with nonalcoholic steatohepatitis

By  

HEPATOLOGY, Vol. 56, Iss. 1, 2012-07 ,pp. : 118-129

John Wiley & Sons Inc

Access to resources Recommend Favorite

Altered morphine glucuronide and bile acid disposition in patients with nonalcoholic steatohepatitis

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 97, Iss. 4, 2015-04 ,pp. : 419-427

John Wiley & Sons Inc

Access to resources Recommend Favorite